Humanigen analyst ratings
Humanigen analyst ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 09/10/2021 | 201% | Jefferies | $37 → $9 | Downgrades | Buy → Hold |
| 09/09/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 09/09/2021 | 836.45% | HC Wainwright & Co. | $36 → $28 | Maintains | Buy |
| 08/13/2021 | 702.68% | Credit Suisse | $25 → $24 | Maintains | Outperform |
| 08/10/2021 | 970.23% | Roth Capital | $37 → $32 | Maintains | Buy |
| 06/11/2021 | 836.45% | Credit Suisse | → $28 | Initiates Coverage On | → Outperform |
| 05/07/2021 | 903.34% | Oppenheimer | → $30 | Initiates Coverage On | → Outperform |
| 04/12/2021 | 1104.01% | HC Wainwright & Co. | $34 → $36 | Reiterates | → Buy |
| 12/23/2020 | 1070.57% | National Securities Corporation | → $35 | Initiates Coverage On | → Buy |
| 12/22/2020 | 803.01% | Jefferies | → $27 | Initiates Coverage On | → Buy |
| 10/21/2020 | 736.12% | Cantor Fitzgerald | → $25 | Initiates Coverage On | → Overweight |
| 10/14/2020 | 936.79% | HC Wainwright & Co. | → $31 | Initiates Coverage On | → Buy |
| 10/01/2020 | 736.12% | Roth Capital | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/13/2022 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 2021 年 10 月 9 日 | 201% | 傑富瑞集團 | 37 美元 → 9 美元 | 降級 | 買入 → 持有 |
| 2021 年 9 月 9 日 | — | 摩根大通 | 降級 | 中性 → 體重不足 | |
| 2021 年 9 月 9 日 | 836.45% | HC Wainwright & Co. | 36 美元 → 28 美元 | 維護 | 買 |
| 08/13/2021 | 702.68% | 瑞士信貸 | 25 美元 → 24 美元 | 維護 | 跑贏大盤 |
| 08/10/2021 | 970.23% | 羅斯資本 | 37 美元 → 32 美元 | 維護 | 買 |
| 06/11/2021 | 836.45% | 瑞士信貸 | → 28 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 05/07/2021 | 903.34% | 奧本海默 | → 30 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 2021 年 12 月 4 日 | 1104.01% | HC Wainwright & Co. | 34 美元 → 36 美元 | 重申 | → 購買 |
| 12/23/2020 | 1070.57% | 國家證券公司 | → 35 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 12/22/2020 | 803.01% | 傑富瑞集團 | → 27 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 10/21/2020 | 736.12% | 坎託·菲茨傑拉德 | → 25 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 2020 年 10 月 14 日 | 936.79% | HC Wainwright & Co. | → 31 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2020 年 1 月 10 日 | 736.12% | 羅斯資本 | → 25 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Humanigen Questions & Answers
Humanigen 問題與解答
The latest price target for Humanigen (NASDAQ: HGEN) was reported by HC Wainwright & Co. on July 13, 2022. The analyst firm set a price target for $0.00 expecting HGEN to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2022年7月13日公佈了Humanigen（納斯達克股票代碼：HGEN）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計HGEN將在12個月內跌至-100.00％（可能下跌100.00％）。去年有6家分析公司公佈了評級。
The latest analyst rating for Humanigen (NASDAQ: HGEN) was provided by HC Wainwright & Co., and Humanigen downgraded their neutral rating.
HC Wainwright & Co. 對Humanigen（納斯達克股票代碼：HGEN）的最新分析師評級由HC Wainwright & Co. 提供，Humanigen下調了中性評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen was filed on July 13, 2022 so you should expect the next rating to be made available sometime around July 13, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Humanigen的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Humanigen的最新評級是在2022年7月13日發佈的，因此您應該預計下一個評級將在2023年7月13日左右公佈。
While ratings are subjective and will change, the latest Humanigen (HGEN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Humanigen (HGEN) is trading at is $2.99, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Humanigen（HGEN）評級已下調，目標股價爲0.00美元至0.00美元。Humanigen（HGEN）目前的交易價格爲2.99美元，超出了分析師的預期區間。